Sh15,000.00
Aspa sweet Tablets (Aspartame (or APM) is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages. aspartame is safe at current levels of consumption as a non-nutritive sweetener. It is approximately 200 times sweeter than sucrose or table sugar, and the quantity of aspartame needed to produce a sweet taste is so small that its caloric contribution is negligible.
| Settings | Aspa Sweet 450 Tablets remove | Amoxyclav Spotcav 375mg Tablets remove | 223 BIG SOAP 100gm remove | ALOE VERA MOISTURISING CREAM 150ML remove | Acefen Tablets remove | Amoxyclav Spotcalv 625mg Tablets remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh15,000.00 | Sh9,000.00 | Sh3,500.00 | Sh6,000.00 | Sh6,000.00 | Sh6,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | It is used to treat infections of:
|
| ||||
| Content | Aspa sweet Tablets (Aspartame (or APM) is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages. aspartame is safe at current levels of consumption as a non-nutritive sweetener. It is approximately 200 times sweeter than sucrose or table sugar, and the quantity of aspartame needed to produce a sweet taste is so small that its caloric contribution is negligible. | Amoxyclav 375 Tablet is a penicillin-type of antibiotic that helps your body fight infections caused by bacteria. It will not work for viral infections such as the common cold. |
|
| Acefen Tablet is a combination of Ibuprofen and Paracetamol, a pain-relieving medicine. | Amoxicillin/clavulanic acid is a combination penicillin-type antibiotics used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu) |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.